‘Malaria vaccine still has many hurdles to cross’

•Scientists hail historic malaria jab approval but point to challenges ahead •Say WHO-approved RTS,S vaccine has modest efficacy, requires complex regimen of doses •At N3,250 per dose, vaccine rollout would cost N211.25b yearly to administer in ten African countries Scientists